BioForm Medical, San Mateo, Calif, announced that the FDA has approved its injectable wrinkle filler, Radiesse, to treat facial fat loss in people with human immunodeficiency virus.

Radiesse, which contains a synthetic bone-like material that stimulates collagen growth, has been used in reconstructive facial surgeries in the US since 2002, the Wall Street Journal reports.

An FDA study of 117 patients who received both Radiesse and Cosmoplast, a collagen, found there was no difference in adverse side effects between the two treatments.

According to the company, Radiesse treatments will cost $850 annually. The treatment was also approved to treat moderate to severe facial wrinkles.

[www.medicalnewstoday.com, January 4, 2007]